EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Adenosine A2A Receptor Up-Regulation Pre-Dates Deficits of Synaptic Plasticity and of Memory in Mice Exposed to Aβ1–42 to Model Early Alzheimer’s Disease

Cátia R Lopes, António C Silva iD, Henrique B Silva iD, Paula M Canas, Paula Agostinho, Rodrigo A Cunha iD, João Pedro Lopes iD

Biomolecules · 2023

DOI: 10.3390/biom13081173 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, 2023. Verfasst von Cátia R Lopes und 6 weiteren Autor:innen. Beteiligte Einrichtung: CNC-Center for Neuroscience and Cell Biology, University of Coimbra, 3004-504 Coimbra, Portugal. Hauptthemen laut MEDLINE: Alzheimer Disease. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 99 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: La Caixa Foundation, Centro 2020, FCT.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The intracerebroventricular (icv) injection of amyloid peptides (Aβ) models Alzheimer’s disease (AD) in mice, as typified by the onset within 15 days of deficits of memory and of hippocampal long-term potentiation (LTP) that are prevented by the blockade of adenosine A2A receptors (A2AR). Since A2AR overfunction is sufficient to trigger memory deficits, we tested if A2AR were upregulated in hippocampal synapses before the onset of memory deficits to support the hypothesis that A2AR overfunction could be a trigger of AD. Six to eight days after Aβ-icv injection, mice displayed no alterations of hippocampal dependent memory; however, they presented an increased excitability of hippocampal synapses, a slight increase in LTP magnitude in Schaffer fiber-CA1 pyramid synapses and an increased density of A2AR in hippocampal synapses. A2AR blockade with SCH58261 (50 nM) normalized excitability and LTP in hippocampal slices from mice sacrificed 7–8 days after Aβ-icv injection. Fifteen days after Aβ-icv injection, mice displayed evident deficits of hippocampal-dependent memory deterioration, with reduced hippocampal CA1 LTP but no hyperexcitability and a sustained increase in synaptic A2AR, which blockade restored LTP magnitude. This shows that the upregulation of synaptic A2AR precedes the onset of deterioration of memory and of hippocampal synaptic plasticity, supporting the hypothesis that the overfunction of synaptic A2AR could be a trigger of memory deterioration in AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseAnimalsMiceUp-RegulationReceptor, Adenosine A2ANeuronal PlasticityAdenosineMemory DisordersPeptide FragmentsAmyloid beta-Peptides

Stichwörter der Autor:innen

A2A receptorAlzheimer’s diseaseLTPadenosinememorysynapse

Substanzen

Receptor, Adenosine A2AAdenosineamyloid beta-protein (1-42)Peptide FragmentsAmyloid beta-Peptides

Autor:innen und Institutionen

  • CNC-Center for Neuroscience and Cell Biology, University of Coimbra, 3004-504 Coimbra, Portugal.
  • Faculty of Medicine, University of Coimbra, 3000-370 Coimbra, Portugal.

ORCID-Profile: António C Silva, Henrique B Silva, Rodrigo A Cunha, João Pedro Lopes

Förderung

  • La Caixa Foundation
  • Centro 2020
  • FCT

Zitieren

APA

Lopes, C. R., Silva, A. C., Silva, H. B., Canas, P. M., Agostinho, P., Cunha, R. A., & Lopes, J. P. (2023). Adenosine A2A Receptor Up-Regulation Pre-Dates Deficits of Synaptic Plasticity and of Memory in Mice Exposed to Aβ1–42 to Model Early Alzheimer’s Disease. Biomolecules. https://doi.org/10.3390/biom13081173

Vancouver

Lopes CR, Silva AC, Silva HB, Canas PM, Agostinho P, Cunha RA, et al. Adenosine A2A Receptor Up-Regulation Pre-Dates Deficits of Synaptic Plasticity and of Memory in Mice Exposed to Aβ1–42 to Model Early Alzheimer’s Disease. Biomolecules. 2023. doi:10.3390/biom13081173

BibTeX
@article{Lopes2023,
  author = {Lopes, Cátia R and Silva, António C and Silva, Henrique B and Canas, Paula M and Agostinho, Paula and Cunha, Rodrigo A and Lopes, João Pedro},
  title = {Adenosine A2A Receptor Up-Regulation Pre-Dates Deficits of Synaptic Plasticity and of Memory in Mice Exposed to Aβ1–42 to Model Early Alzheimer’s Disease},
  journal = {Biomolecules},
  year = {2023},
  doi = {10.3390/biom13081173}
}
Kostenlos starten →